Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AirMatrix Appoints Former Under Secretary of the Navy Gregory J. Slavonic as Board Member
-
Workers at StellerVista Credit Union (formerly Heritage Credit Union) in Castlegar and Slocan Park serve 72-hour strike notice
-
Tevogen Bio Announces 2025 Annual Meeting
-
XRP News: Only 3 Days Left to Join XploraDEX Presale as $XPL Token Distribution Enters Final Stage
-
XRP News: XenDex Surpasses 10% Presale Allocation Within Hours of Launch
-
Priority Income Fund Announces Intent to Seek Public Listing of Shares of Common Stock
-
PER® Presents More Than a Dozen Free CME/CE Symposia at the Annual Oncology Meeting in Chicago
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xponential Fitness, Inc. - XPOF
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRobot Corporation - IRBT
-
AGCO and Woodbine Entertainment Group reach settlement following investigation into track safety at Woodbine Racetrack
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of XP Inc. - XP
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RLX Technology Inc. - RLX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Affirm Holdings, Inc. - AFRM
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
-
End of Day Message
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY
-
Meridian Corporation Reports First Quarter 2025 Results and Announces a Quarterly Dividend of $0.125 per Common Share
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bitfarms Ltd. - BITF
-
Top Technology Executives Recognized at the 2025 HoustonCIO ORBIE Awards
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KinderCare Learning Companies, Inc. - KLC
-
Joseph Schnaier Launches $1,000 National Scholarship to Support and Cultivate Future Finance Leaders in U.S. Undergraduate Programs
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pony AI Inc. - PONY
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO
-
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
-
Willms and Associates Named Rockford Mutual 2024 Agency of the Year
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of 3D Systems Corporation - DDD
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Endeavour Silver Corp. - EXK
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
-
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Ann
-
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC
-
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
-
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
-
DTE Completes Construction on Pine River Solar Park
-
IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
-
SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED
-
Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
-
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
-
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
-
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
-
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
-
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Open Lending Corp. - LPRO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Greenbrier Companies, Inc. - GBX
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Watsco, Inc. - WSO
-
American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida

